Efgartigimod IV for Seronegative Generalized Myasthenia Gravis

Efgartigimod IV for Seronegative Generalized Myasthenia Gravis
72%49%27%Apr 26Apr 27Apr 28Apr 29Apr 30May 1May 2May 3May 4May 5May 6May 7May 8May 9May 10May 11May 12May 13Apr 26 • YES 58.0%Apr 27 • YES 34.0%Apr 28 • YES 34.0%Apr 29 • YES 34.0%Apr 30 • YES 34.0%May 1 • YES 34.0%May 2 • YES 34.0%May 3 • YES 34.0%May 4 • YES 34.0%May 5 • YES 34.0%May 7 • YES 60.1%May 12 • YES 60.1%May 13 • YES 64.7%
argenx ($ARGX)
No stock closeNo stock close$819.4$794.2$768.9Apr 26Apr 27Apr 28Apr 29Apr 30May 1May 2May 3May 4May 5May 6May 7May 8May 9May 10May 11May 12May 13Apr 27 • ARGX $783.7Apr 28 • ARGX $775.0Apr 29 • ARGX $776.0Apr 30 • ARGX $781.7May 1 • ARGX $783.5May 4 • ARGX $811.1May 5 • ARGX $794.7May 6 • ARGX $807.6May 7 • ARGX $787.3May 8 • ARGX $782.2May 11 • ARGX $813.3

Will this trial show a positive result on MG-ADL total score change from baseline?

Paper Trading
Create account to trade
ClinicalTrialModel PositionsModel ReasoningOracle
No oracle findings have been stored for this trial yet.
Stats
Latest Run
No runs yet
Model
No runs yet
Runs
0 runs